Companies sponsors |
CSL Behring (garadacimab) |
Others |
Department of Health and Social Care |
|
NHS England |
Patient carer groups |
Action for Children |
|
Allergy UK |
|
Anaphylaxis UK |
|
Asthma and Lung UK |
|
Genetic Alliance UK |
|
HAE UK |
|
Immunodeficiency UK |
|
Jnetics |
|
NARA - The Breathing Charity |
|
National Children’s Bureau |
|
South Asian Health Foundation |
|
Specialised Healthcare Alliance |
|
UK Primary Immune-deficiency Patient Support Charity (UKPIPS) |
Professional groups |
Association for Respiratory Technology and Physiology |
|
Association of Genetic Nurses & Counsellors |
|
Association of Paediatric Emergency Medicine |
|
British Geriatrics Society |
|
British Paediatric Allergy, Immunity and Infection Group (BPAIIG) |
|
British Paediatric Respiratory Society |
|
British Skin Foundation |
|
British Society for Allergy & Clinical Immunology |
|
British Society for Gene and Cell Therapy |
|
British Society for Genetic Medicine |
|
British Society for Haematology |
|
British Society for Immunology |
|
British Thoracic Society |
|
BSI Clinical Immunology Professional Network (BSI-CIPN) |
|
ILD-IN: Interstitial Lung Diseases Interdisciplinary Network |
|
Immunology and Allergy Nurses Group |
|
National Heart and Lung Institute |
|
Neonatal and Paediatric Pharmacists Group |
|
Primary Care Respiratory Society UK |
|
Royal College of General Practitioners |
|
Royal College of Nursing |
|
Royal College of Paediatrics & Child Health |
|
Royal College of Pathologists |
|
Royal College of Physicians |
|
Royal Pharmaceutical Society |
|
Royal Society of Medicine |
|
Royal Society of Medicine - Allergy and Immunology Section |
|
UK Clinical Pharmacy Association |
|
UK Forum on Haemoglobin Disorders |
Associated public health groups |
Public Health Wales |
|
UK Health Security Agency |
Comparator companies |
BioCryst Pharmaceuticals (berotralstat) |
|
CSL Behring (Berinert) |
|
Maxwellia (tranexamic acid) |
|
Mylan (tranexamic acid) |
|
Pharming Group N.V (Ruconest) |
|
Rivopharm (tranexamic acid) |
|
Sovereign Medical (tranexamic acid) |
|
Takeda (Cinryze, lanadelumab) |
|
Tillomed Laboratories (tranexamic acid) |
General commentators |
All Wales Therapeutics and Toxicology Centre |
|
Allied Health Professionals Federation |
|
Board of Community Health Councils in Wales |
|
British National Formulary |
|
Care Quality Commission |
|
Cell and Gene Therapy Catapult |
|
Department of Health, Social Services and Public Safety for Northern Ireland |
|
Healthcare Improvement Scotland |
|
Hospital Information Services – Jehovah’s Witnesses |
|
Medicines and Healthcare products Regulatory Agency |
|
National Association of Primary Care |
|
National Pharmacy Association |
|
NHS Alliance |
|
NHS Confederation |
|
Scottish Medicines Consortium |
|
Welsh Government |
|
Welsh Health Specialised Services Committee |
Relevant research groups |
Asthma, Allergy and Inflammation Research Trust |
|
British Association for Lung Research |
|
Cochrane Airways Group |
|
Cochrane UK |
|
David Hide Asthma and Allergy Research Centre |
|
Genomics England |
|
MRC Clinical Trials Unit |
|
National Institute for Health Research |